Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
June 4, 2014
Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics
Angelo Paci, Gareth Veal, Christophe Bardin, et al.
BMJ Open
|
June 27, 2025
Randomised controlled trial to assess the impact of hospital-community pharmaceutical care on drug-related problems in oncology practice for at-risk outpatients treated with oral anticancer drugs-a French Society for Oncology Pharmacy (SFPO) study: DROP-SFPO study protocol
Florence Ranchon, Laure Huot, Christophe Bardin, et al.
European Journal of Hospital Pharmacy : Science and Practice
|
July 21, 2021
Pilot study of a European oncology regimen reference library and matching algorithm
Mirjam Crul, Robert Terkola, Christophe Bardin, et al.
BMC Pharmacology & Toxicology
|
August 7, 2013
Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes
Saik Urien, Christophe Bardin, Brigitte Bader-Meunier, et al.
Clinical Pharmacokinetics
|
September 12, 2009
Pharmacology of morphine in obese patients: clinical implications
Célia Lloret Linares, Xavier Declèves, Jean Michel Oppert, et al.
Clinical Pharmacokinetics
|
August 22, 2014
Effect of a Roux-en-Y gastric bypass on the pharmacokinetics of oral morphine using a population approach
Célia Lloret-Linares, Déborah Hirt, Christophe Bardin, et al.
Antimicrobial Agents and Chemotherapy
|
July 8, 2009
Didanosine population pharmacokinetics in West African human immunodeficiency virus-infected children administered once-daily tablets in relation to efficacy after one year of treatment
Déborah Hirt, Christophe Bardin, Serge Diagbouga, et al.
Antimicrobial Agents and Chemotherapy
|
June 3, 2010
Is the recommended once-daily dose of lamivudine optimal in West African HIV-infected children?
Naïm Bouazza, Déborah Hirt, Christophe Bardin, et al.
Annales Pharmaceutiques Francaises
|
October 10, 2025
The evolving role of Hospital Oncology Pharmacists (HOPs) in assessing therapeutic innovations and managing toxicities in cancer care
Florence Ranchon, Florian Slimano, Maha Ayyoub, et al.
Cancer Treatment Reviews
|
July 6, 2020
Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)
Florian Slimano, Amandine Baudouin, Jérémie Zerbit, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
European Journal of Cancer (Oxford, England : 1990)
|
June 4, 2014
Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics
Angelo Paci, Gareth Veal, Christophe Bardin, et al.
BMJ Open
|
June 27, 2025
Randomised controlled trial to assess the impact of hospital-community pharmaceutical care on drug-related problems in oncology practice for at-risk outpatients treated with oral anticancer drugs-a French Society for Oncology Pharmacy (SFPO) study: DROP-SFPO study protocol
Florence Ranchon, Laure Huot, Christophe Bardin, et al.
European Journal of Hospital Pharmacy : Science and Practice
|
July 21, 2021
Pilot study of a European oncology regimen reference library and matching algorithm
Mirjam Crul, Robert Terkola, Christophe Bardin, et al.
BMC Pharmacology & Toxicology
|
August 7, 2013
Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes
Saik Urien, Christophe Bardin, Brigitte Bader-Meunier, et al.
Clinical Pharmacokinetics
|
September 12, 2009
Pharmacology of morphine in obese patients: clinical implications
Célia Lloret Linares, Xavier Declèves, Jean Michel Oppert, et al.
Clinical Pharmacokinetics
|
August 22, 2014
Effect of a Roux-en-Y gastric bypass on the pharmacokinetics of oral morphine using a population approach
Célia Lloret-Linares, Déborah Hirt, Christophe Bardin, et al.
Antimicrobial Agents and Chemotherapy
|
July 8, 2009
Didanosine population pharmacokinetics in West African human immunodeficiency virus-infected children administered once-daily tablets in relation to efficacy after one year of treatment
Déborah Hirt, Christophe Bardin, Serge Diagbouga, et al.
Antimicrobial Agents and Chemotherapy
|
June 3, 2010
Is the recommended once-daily dose of lamivudine optimal in West African HIV-infected children?
Naïm Bouazza, Déborah Hirt, Christophe Bardin, et al.
Annales Pharmaceutiques Francaises
|
October 10, 2025
The evolving role of Hospital Oncology Pharmacists (HOPs) in assessing therapeutic innovations and managing toxicities in cancer care
Florence Ranchon, Florian Slimano, Maha Ayyoub, et al.
Cancer Treatment Reviews
|
July 6, 2020
Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)
Florian Slimano, Amandine Baudouin, Jérémie Zerbit, et al.
Page
of 3